Juvenile absence epilepsy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Apr 2026

VALPROIC ACID: New indication approved

FDAcompleted
Mar 2026

VALPROIC ACID: New indication approved

FDAcompleted
Mar 2026

VALPROIC ACID: New indication approved

FDAcompleted
Feb 2025

VALPROIC ACID: New indication approved

FDAcompleted
Jan 2022

VALPROIC ACID: New indication approved

FDAcompleted
Apr 2020

VALPROIC ACID: New indication approved

FDAcompleted
Dec 2019

VALPROIC ACID: New indication approved

FDAcompleted
Nov 2015

VALPROIC ACID: New indication approved

FDAcompleted
Dec 2014

VALPROIC ACID: New indication approved

FDAcompleted
Jan 2011

VALPROIC ACID: New indication approved

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Valproic Acid

Direct_Rx

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Valproic Acid

(VALPROIC ACID)Orphan drugstandard

Direct_Rx

Anti-epileptic Agent [EPC]

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Juvenile absence epilepsy.
Search all trials →
Search clinical trials for Juvenile absence epilepsy

Recent News & Research

No recent news articles indexed yet for Juvenile absence epilepsy.
Search PubMed for Juvenile absence epilepsy

Browse all Juvenile absence epilepsy news →

Specialist Network

Top 6 by expertise

View all Juvenile absence epilepsy specialists →

Quick Actions